Severe strongyloidiasis in corticosteroid-treated patients

被引:61
|
作者
Fardet, L. [1 ]
Genereau, T. [1 ]
Kettaneh, A. [1 ]
机构
[1] Hop St Antoine, Dept Internal Med, F-75012 Paris, France
关键词
corticosteroids; diagnosis; ivermectine; Strongyloides stercoralis; treatment;
D O I
10.1111/j.1469-0691.2006.01443.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Severe strongyloidiasis, caused by Strongyloides stercoralis, is a preventable life-threatening disease that can occur in any corticosteroid-treated patient who has travelled to a country with infested soil, even if the contact occurred up to 30 years previously. This diagnosis should be considered in corticosteroid-treated patients who experience either unusual gastrointestinal or pulmonary symptoms, or who suffer from unexplained sepsis caused by Gram-negative bacilli. Peripheral eosinophilia is not observed systematically and, even if present, is moderate in most cases. Ivermectine is the best prophylactic and therapeutic option, and thiabendazole should no longer be used. However, guidelines for the prevention and management of S. stercoralis infection in such patients have not yet been established.
引用
收藏
页码:945 / 947
页数:3
相关论文
共 50 条
  • [31] Quantitative ultrasound at the calcaneus in corticosteroid-treated male patients with bronchial asthma
    Drozdzowska, B
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2004, 30 (08): : 1057 - 1061
  • [32] FREQUENCY AND SIGNIFICANCE OF CHRONIC ULCERATIVE-COLITIS IN SEVERE CORTICOSTEROID-TREATED AUTOIMMUNE HEPATITIS
    PERDIGOTO, R
    CZAJA, AJ
    [J]. HEPATOLOGY, 1990, 12 (04) : 959 - 959
  • [33] HUMORAL AND HOMOGRAFT IMMUNITY IN CORTICOSTEROID-TREATED CHICKS
    SATO, K
    GLICK, B
    [J]. POULTRY SCIENCE, 1969, 48 (05) : 1866 - &
  • [34] Cognition and Dorsolateral Prefrontal Cortex Volume in Corticosteroid-treated Patients given Lamotrigine
    Husain, Saira
    Kuzminski, Samuel
    Shad, Mujeeb U.
    Gabrielson, Barry
    Bret, Mary E.
    Osuji, I. Julian
    Brown, E. Sherwood
    [J]. STRESS AND HEALTH, 2011, 27 (01) : 18 - 22
  • [35] AN EPIDEMIOLOGIC-STUDY OF RISK-FACTORS FOR OSTEOPOROSIS IN CORTICOSTEROID-TREATED PATIENTS
    JOSEPH, JC
    SORKNESS, CA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 339 - 339
  • [36] CLINICAL-FEATURES AND PROGNOSTIC IMPLICATIONS OF SEVERE CORTICOSTEROID-TREATED CRYPTOGENIC CHRONIC ACTIVE HEPATITIS
    CZAJA, AJ
    HAY, JE
    RAKELA, J
    [J]. MAYO CLINIC PROCEEDINGS, 1990, 65 (01) : 23 - 30
  • [37] Prevalence and Predictors of Fragility Fracture in Corticosteroid-treated Patients with Autoimmune Hepatitis (AIH)
    Harrison, Laura
    Dhaliwal, Harpreet
    Peel, Nicola
    McFarlane, Elaine
    Gleeson, Dermot
    Karajeh, Mohammed
    [J]. HEPATOLOGY, 2016, 64 : 816A - 816A
  • [38] PNEUMOCYSTIS-CARINII INFECTION IN CORTICOSTEROID-TREATED CATS
    SHIOTA, T
    SHIMADA, Y
    KURIMOTO, H
    OIKAWA, H
    [J]. JOURNAL OF PARASITOLOGY, 1990, 76 (03) : 441 - 445
  • [39] PLASMA GROWTH HORMONE CONCENTRATION IN CORTICOSTEROID-TREATED CHILDREN
    MORRIS, HG
    JORGENSE.JR
    JENKINS, SA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (03): : 427 - &
  • [40] Obesity prevention in corticosteroid-treated patients: Use and effectiveness of strategies for weight management
    Conklin, Annalijn I.
    Hong, Jenny
    [J]. CLINICAL OBESITY, 2019, 9 (04)